Oh Steini you are so right, I bought into ALA when they started the collaboration, although impressed by their technology I am staggered to see how their sp can be so far above IMU.
When you compare where they are at in their clinical trial and that their NK Cells are their only IP, one can only shake one's head when comparing value.
I know you shouldn't compare biotech companies like this but it just sticks out so much how undervalued Imugene are.
DYOR opinion only
Media Thread, page-14745
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.6¢ |
Change
-0.001(0.89%) |
Mkt cap ! $411.5M | |||
| Open | High | Low | Value | Volume |
| 5.6¢ | 5.6¢ | 5.4¢ | $345.2K | 6.268M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 18 | 767060 | 5.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.6¢ | 253644 | 14 |
View Market Depth
| Last trade - 14.46pm 19/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |